Dr Thomas Hanke
Head of Academic Partnerships at Evotec
Since November 2016, Thomas has been responsible for strategic academic partnerships at Evotec. From November 2013, Thomas has been EVP of Immunology and Inflammation, heading a portfolio of drug discovery projects in the areas of inflammation and immuno-oncology at Evotec. During this time, Thomas’ focus has been on building high-value, performance based drug discovery alliances with academia and pharma.
Dr. Hanke is in Oxford as LAB282's expert in residence and is working closely with academics and with Oxford University Innovation to source and manage funded projects.
Please contact Carolyn Porter if you would like to discuss projects: